Patents for A61P 35 - Antineoplastic agents (221,099)
10/2004
10/06/2004EP1463438A2 Endomural therapy
10/06/2004EP1383481B1 Process for manufacture of biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/06/2004EP1379262B1 Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles
10/06/2004EP1349868B1 Process to concentrate insoluble proteins by vibrating membrane filtration
10/06/2004EP1318837B1 Method of treating estrogen receptor positive carcinoma
10/06/2004EP1303632B1 Galactomannan oligosaccharides and methods for the production and use thereof
10/06/2004EP1282395B1 Use of ellagic acid as anti-pollution cosmetic agent
10/06/2004EP1272652B1 Herpes viruses for immune modulation
10/06/2004EP1248787B1 NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
10/06/2004EP1144414B1 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
10/06/2004EP1135379B1 Antitumor dibenzofluorene derivatives
10/06/2004EP1108050B1 Methods and compositions for expressing heterologous genes in hepatocytes using hepadnaviral vectors
10/06/2004EP1062514B1 C-myc coding region determinant-binding protein (crd-bp)
10/06/2004EP0970070B1 Phthalazines with angiogenesis inhibiting activity
10/06/2004EP0868425B1 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
10/06/2004EP0840608B1 Orotate salts of 5-amino or substituted amino 1,2,3-triazoles for treatment of neoplasms
10/06/2004EP0808309B1 Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors
10/06/2004EP0706563B1 A truncated keratinocyte growth factor (kgf) having increased biological activity
10/06/2004CN1535312A PUFA polyketide synthase systems and uses thereof
10/06/2004CN1535282A Ganalioside-associated recombinant antibodies and use thereof in diagnosis and treatment of tumours
10/06/2004CN1535281A Peptides and related molecules that bind to TALL-1
10/06/2004CN1535168A Controlled release composition and method of producing the same
10/06/2004CN1535163A Delivery system for nucleic acids
10/06/2004CN1535159A Medicine box containing anti human spermatine single chain antibody/human carboxypeptidase A fusion progein and precusor medicine
10/06/2004CN1535156A Use of disintegrain domain of adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
10/06/2004CN1535151A Novel anti-infectives
10/06/2004CN1534047A 新的脱乙酰壳多糖 The new chitosan
10/06/2004CN1534044A Recombination human interferon alpha 8 polypeptide coding cDNA sequence preparation method and application
10/06/2004CN1534043A Ubiquition type molecule of human bone marrow substrate cell source and its coding sequence and use
10/06/2004CN1534026A Condensed quinazoline derirative used as tyrosine kinase inhibitor
10/06/2004CN1534017A N-(2-phenyl-4-amino-batyl)-1-naphthol carboxy amide kind compound used as neuropeptide-1-acceptor antagonistic agent
10/06/2004CN1533807A High dosage recombination human alpha interferon oral tablet and its manufacturing method
10/06/2004CN1533797A Antiadenocarcinoma medicine for treating adeno kind cancer
10/06/2004CN1533765A Preparaton method of anticancer medicine colchicin microsphere freeze dried agent
10/06/2004CN1169966C Isolated, tyrosinase derived peptides and uses thereof
10/06/2004CN1169959C Polypeptide variants with raised heparin-binding capacity
10/06/2004CN1169958C Coding of human protein polynucleotide able to suppress growth of cancer cells
10/06/2004CN1169957C Coding of human protein polynucleotide able to suppress growth of cancer cells
10/06/2004CN1169956C Coding of human protein polynucleotide able to suppress growth of cancer cells
10/06/2004CN1169953C CD3-resisting single clone antibody heavy-chain and light-chain variable-area gene and its application
10/06/2004CN1169952C Heavy chain and light chain variable region gene of anti-CD 20 monoclonal antibody and its application
10/06/2004CN1169949C Preparation of recombination adenovirus construction body with deletion E1A code sequence and its use
10/06/2004CN1169835C Human B lymphocyte stimulating factor mutant and constructing method and coding gene thereof
10/06/2004CN1169831C Human protein with cancer call growth suppressing function and its coding sequence
10/06/2004CN1169824C Polytype gene of MXA protein and application thereof
10/06/2004CN1169810C Peptide nucleic acid derivatives and preparing process, intermediate for preparing them and medicinal composition containing them
10/06/2004CN1169808C 'Beta'-carboline compound
10/06/2004CN1169802C Corter pseudolaricis acetic acid composition and its preparing process
10/06/2004CN1169788C N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
10/06/2004CN1169768C (4-alkynyl), aromatic keto-acid compound, synthesis method and its application
10/06/2004CN1169579C Medicine C60-AEDP using C60 as carrier for target therapy of osteopath and its usage
10/06/2004CN1169575C Human tumor necrosis factor-alpha oral prepn. of marine polychlorella
10/06/2004CN1169556C Medicine for curing cancers
10/06/2004CN1169531C Process for producing freezed dried centipede
10/06/2004CN1169527C Methods of modulating serine-threnoine protein kinase function with 5-azaquinoxaline-based compounds
10/06/2004CN1169525C Pharmaceutical formulations for taxanes
10/06/2004CN1169523C Slow-releasing Tamoxifen citrate tablet
10/05/2004US6800778 Process for producing optically active naphthalene derivative and optical resolver therefor
10/05/2004US6800760 Inhibitors of vascular endothelial growth factor receptor tyrosine kinase
10/05/2004US6800737 Amino acid sequences; anticaner agents, monitoring, diagnosis
10/05/2004US6800660 Bis(thio-hydrazide amide) compounds; anticancer agents
10/05/2004US6800659 Compounds for modulating cell proliferation
10/05/2004US6800655 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
10/05/2004US6800654 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/05/2004US6800653 Anticancer agents
10/05/2004US6800645 Substituted azabicyclic compounds
10/05/2004US6800639 Dioxolane nucleosides and nucleoside analogues such as troxacitabine together with chemotherapeutic agents other than doxorubicin such as cytarabine, gemcitabine and idarubicin; synergistic mixture; treating leukemia, cancer
10/05/2004US6800638 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors
10/05/2004US6800636 Farnesyl protein transferase inhibitors
10/05/2004US6800632 Bicyclic inhibitors of glycogen synthase kinase 3
10/05/2004US6800630 Cytostatic activity, inhibitory activity against a signal derived from ras oncogene products
10/05/2004US6800626 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc.
10/05/2004US6800624 Sulfonamide and sulfamide substituted imidazoquinolines
10/05/2004US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives
10/05/2004US6800611 Metastin derivatives and their use
10/05/2004US6800609 Isolated peptide of the horny layer and user thereof
10/05/2004US6800605 With a hypolipidemic agent, an antidiabetic agent, an antidepressant, a bone resorption inhibitor, an appetite suppressant and/or an anti-obesity agent
10/05/2004US6800483 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
10/05/2004US6800471 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/05/2004US6800470 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
10/05/2004US6800446 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
10/05/2004US6800441 Heparanase specific molecular probes and their use in research and medical applications
10/05/2004US6800434 Peptides as NS3-serine protease inhibitors of hepatitis C virus
10/05/2004US6800290 Variants can be used in specific immunotherapy of allergic pathologies caused by dust mites
10/05/2004CA2128833C P53as protein and antibody therefor
09/2004
09/30/2004WO2004083864A1 Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 3 (par3)
09/30/2004WO2004083434A1 A combined adeno-associated virus and adenovirus cocktail gene delivery system for high effiency gene expression without eliciting immune response in immuno-competent subjects
09/30/2004WO2004083430A2 SHORT INTERFERING RNA (siRNA) ANALOGUES
09/30/2004WO2004083392A2 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
09/30/2004WO2004083365A2 Compounds and their use for specific and simultaneous inhibition of genes involved in diseases and related drugs
09/30/2004WO2004083257A1 Proteoglycan isolated from cartilaginous fish and process for producing the same
09/30/2004WO2004083240A2 Regulation of gene expression
09/30/2004WO2004083239A1 Determining drug resistance
09/30/2004WO2004083231A2 Use of peptide ligands for plasma membrane receptors or similar for mitochondrial activity modulation
09/30/2004WO2004083223A1 Protein-bound derivatives of platinum complexes containing cyclobutane 1.1-dicarboxyllate ligands
09/30/2004WO2004083214A1 7-imino derivatives of camptothecin having antitumor activity
09/30/2004WO2004083203A1 Compositions useful as protein kinase inhibitors
09/30/2004WO2004083186A1 Therapeutic agent for viral hepatitis and carcinostatic agent
09/30/2004WO2004083184A1 Receptor antagonist
09/30/2004WO2004083167A1 Sulfamide derivative and medicinal composition thereof